Earnest Partners LLC trimmed its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 589,141 shares of the company’s stock after selling 31,137 shares during the quarter. Earnest Partners LLC owned approximately 0.99% of Molina Healthcare worth $45,175,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently bought and sold shares of the company. Amundi Pioneer Asset Management Inc. bought a new position in Molina Healthcare during the 4th quarter worth approximately $100,000. Zions Bancorporation purchased a new stake in Molina Healthcare in the 3rd quarter worth approximately $118,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Molina Healthcare by 40.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after buying an additional 690 shares during the period. Connable Office Inc. purchased a new stake in Molina Healthcare in the 4th quarter worth approximately $203,000. Finally, Brown Advisory Inc. purchased a new stake in Molina Healthcare in the 4th quarter worth approximately $347,000. Institutional investors and hedge funds own 96.22% of the company’s stock.
In related news, Director Steven J. Orlando sold 1,500 shares of the stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $72.77, for a total value of $109,155.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John C. Molina sold 5,385 shares of the stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $92.88, for a total value of $500,158.80. Following the completion of the transaction, the director now directly owns 414,151 shares in the company, valued at approximately $38,466,344.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 359,890 shares of company stock worth $30,160,285. Insiders own 6.20% of the company’s stock.
Several research firms have weighed in on MOH. JPMorgan Chase & Co. upgraded Molina Healthcare from a “neutral” rating to an “overweight” rating in a report on Tuesday, January 16th. Leerink Swann raised their target price on Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, January 9th. Morgan Stanley lowered their target price on Molina Healthcare from $97.00 to $94.00 and set an “overweight” rating for the company in a research note on Wednesday, February 7th. ValuEngine cut Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Finally, Goldman Sachs initiated coverage on Molina Healthcare in a research note on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price objective for the company. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and six have assigned a buy rating to the company’s stock. Molina Healthcare currently has a consensus rating of “Hold” and a consensus price target of $76.67.
Shares of MOH stock traded up $0.41 during midday trading on Wednesday, reaching $78.29. The company’s stock had a trading volume of 958,613 shares, compared to its average volume of 1,310,324. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.13. Molina Healthcare, Inc. has a 52 week low of $42.56 and a 52 week high of $93.98. The company has a market capitalization of $4,590.62, a PE ratio of -8.69, a P/E/G ratio of 1.36 and a beta of 1.28.
Molina Healthcare (NYSE:MOH) last released its earnings results on Monday, February 12th. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.11. The firm had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Molina Healthcare had a positive return on equity of 17.64% and a negative net margin of 2.58%. equities analysts predict that Molina Healthcare, Inc. will post 3.68 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Earnest Partners LLC Has $45.18 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://ledgergazette.com/2018/03/21/earnest-partners-llc-has-45-18-million-stake-in-molina-healthcare-inc-moh.html.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.